In the past month, the Regen BioPharma Inc (OTCMKTS:RGBP) stock has emerged as one of the more notable gainers from among micro cap stocks and that can be gauged from the gains of 75% that the stock clocked during that period.
The most important trigger for the rally in the Regen stock came about after the company’s patent for a cancer vaccine was approved back on August 17, 2021. At the time, it was revealed that it was going to make a formal announcement once the Regen stock attained pink current status on the OTC Markets.
Hence, it could be argued that things could get even more bullish for the Regen stock once it manages to gain the Pink Current status. At this point in time, the stock is being accumulated heavily by investors and on top of that, it has also attracted the attention of some of the biggest players in the penny stock space over the course of the past month.
At this point in time, it might be a good idea for investors to keep the Regen stock in their watch lists. Moreover, it could also be a good move to keep an eye out for any news with regards to the stock’s Pink Current status on the OTC Markets.